4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-083586
Chief Operating Officer sold 35,378 shares at $161.88 ($5,726,991)
- Chief Operating Officer acquired 35,378 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jacobson Mark L. Chief Operating Officer | 2026-02-26 | Option exercise 10b5-1 | +35,378 | $2.85 | $100,827 | 35,378 | D |
| Jacobson Mark L. Chief Operating Officer | 2026-02-26 | Sale 10b5-1 | −35,378 | $161.88 | $5,726,991 | 0 | D |
| Derivatives | |||||||
| Jacobson Mark L. Chief Operating Officer | 2026-02-26 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −35,378 | 0 | D | ||
| Open-market sales · 35,378 sh · avg $161.88 · $5,726,991 | |||||||
Loading xslF345X05/ownership.xml…